Featured
Read our handpicked blogs, curated for you.
|
Your organization runs thousands of AI models across fraud detection, credit scoring, and customer journeys. Yet a…
|
The Enforcement Horizon: August 2, 2026The industry consensus is dominated by the EU AI Act. As of mid-2026, AI systems…
|
The 2026 Industry Consensus: From Policies to EnforcementThe prevailing consensus among global Tier-1 banks is the…
Recent releases
|
AI in Pharma and Healthcare: AI use cases that actually drive pharma scripts
The conversation around AI in Pharma and Healthcare has been dominated by hype. Predictions about robots replacing reps, algorithms discovering blockbuster drugs overnight, and chatbots taking over…
|
MLR in healthcare: How to cut approval time by half without risk
Every healthcare marketer in India knows the pain of the MLR cycle. Content is drafted, sent for review, marked up, revised, sent back again, and weeks later, the campaign is still waiting for…
|
How to finally prove ROI in pharma marketing
Every pharma CMO in India has faced the same boardroom moment: a director asks, “We’ve spent ₹50 crores on marketing this year. What’s the ROI?” The room falls silent. Spreadsheets shuffle. Activity…
|
Winning HCP engagement beyond metro cities
Healthcare in India doesn’t stop at Mumbai, Delhi, or Bangalore. Beyond the metros lies the bulk of India’s medical ecosystem: doctors in Tier 2 and Tier 3 cities who prescribe at scale, influence…
